JP2017528464A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528464A5 JP2017528464A5 JP2017513207A JP2017513207A JP2017528464A5 JP 2017528464 A5 JP2017528464 A5 JP 2017528464A5 JP 2017513207 A JP2017513207 A JP 2017513207A JP 2017513207 A JP2017513207 A JP 2017513207A JP 2017528464 A5 JP2017528464 A5 JP 2017528464A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- tumor
- cell
- alkyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CN1C2CC(*)CC1CCC2 Chemical compound CN1C2CC(*)CC1CCC2 0.000 description 2
- FPVBKYJZDGHIIV-LJSVPSOQSA-N C[C@H](C1)C23C1N(C)C2CC3 Chemical compound C[C@H](C1)C23C1N(C)C2CC3 FPVBKYJZDGHIIV-LJSVPSOQSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048771P | 2014-09-10 | 2014-09-10 | |
| US62/048,771 | 2014-09-10 | ||
| US201462078845P | 2014-11-12 | 2014-11-12 | |
| US62/078,845 | 2014-11-12 | ||
| US201562146790P | 2015-04-13 | 2015-04-13 | |
| US62/146,790 | 2015-04-13 | ||
| PCT/US2015/049235 WO2016040515A1 (en) | 2014-09-10 | 2015-09-09 | Substituted piperidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528464A JP2017528464A (ja) | 2017-09-28 |
| JP2017528464A5 true JP2017528464A5 (enExample) | 2018-10-18 |
Family
ID=55459535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017513207A Pending JP2017528464A (ja) | 2014-09-10 | 2015-09-09 | 置換ピペリジン化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10577363B2 (enExample) |
| EP (1) | EP3193605A4 (enExample) |
| JP (1) | JP2017528464A (enExample) |
| KR (1) | KR20170047397A (enExample) |
| CN (1) | CN107072207A (enExample) |
| AU (1) | AU2015315182A1 (enExample) |
| BR (1) | BR112017004589A2 (enExample) |
| CA (1) | CA2960280A1 (enExample) |
| EA (1) | EA201790327A1 (enExample) |
| IL (1) | IL250888A0 (enExample) |
| MX (1) | MX2017002986A (enExample) |
| SG (2) | SG11201701597RA (enExample) |
| WO (1) | WO2016040515A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2960274A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamide compounds |
| WO2016040511A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamides as irreversible smyd inhibitors |
| WO2016040502A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Substituted cyclohexylamine compounds |
| MX2017002985A (es) | 2014-09-10 | 2017-11-17 | Epizyme Inc | Inhibidores de smyd. |
| ES2907626T3 (es) * | 2015-02-27 | 2022-04-25 | Seed Res Institute Co Ltd | Método para producir kakeromicina y sus derivados |
| KR102497095B1 (ko) * | 2016-07-28 | 2023-02-06 | 이도르시아 파마슈티컬스 리미티드 | 피페리딘 cxcr7 수용체 조절제 |
| WO2018151678A1 (en) * | 2017-02-15 | 2018-08-23 | Agency For Science, Technology And Research | Compounds for treatment of cancer and epigenetics |
| TWI822724B (zh) * | 2018-01-26 | 2023-11-21 | 瑞士商愛杜西亞製藥有限公司 | 唑-3-羰基]-胺基}-哌啶-3-羧酸(1-嘧啶-2-基-環丙基)-醯胺之結晶型 |
| CN112955215B (zh) | 2018-10-29 | 2024-05-17 | 勃林格殷格翰国际有限公司 | 吡啶基磺酰胺衍生物、药物组合物及其用途 |
| CN112955214B (zh) | 2018-10-29 | 2024-05-07 | 勃林格殷格翰国际有限公司 | 吡啶基磺酰胺衍生物、药物组合物及其用途 |
| WO2021065898A1 (ja) | 2019-09-30 | 2021-04-08 | 日本ケミファ株式会社 | アゼパン誘導体 |
| CN114702552B (zh) * | 2022-03-11 | 2024-05-31 | 苏州思萃免疫技术研究所有限公司 | mTORC2抑制剂 |
| WO2024067708A1 (zh) * | 2022-09-30 | 2024-04-04 | 苏州阿尔脉生物科技有限公司 | 草酸胺类衍生物、包含其的药物组合物及其医药用途 |
| WO2025133989A1 (en) * | 2023-12-20 | 2025-06-26 | Alt-Bio Pte. Ltd. | Smyd modulators and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1228288B (it) * | 1989-01-09 | 1991-06-07 | Zambon Spa | Composti ad attivita' antiserotoninica |
| SE9902987D0 (sv) * | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| SE0403106D0 (sv) | 2004-12-20 | 2004-12-20 | Astrazeneca Ab | Chemical compounds |
| US20090062286A1 (en) * | 2007-05-04 | 2009-03-05 | Kenneth William Foreman | Crystal Structure of SMYD3 Protein |
| TW200930713A (en) * | 2007-12-03 | 2009-07-16 | Takeda Pharmaceutical | Nitrogen-containing heterocyclic compound and use thereof |
| TWI535712B (zh) | 2010-08-06 | 2016-06-01 | 阿斯特捷利康公司 | 化合物 |
| JP5927201B2 (ja) * | 2010-12-16 | 2016-06-01 | カルチャン リミテッド | Ａｓｋ１阻害ピロロピリミジン誘導体 |
| MX2017002985A (es) | 2014-09-10 | 2017-11-17 | Epizyme Inc | Inhibidores de smyd. |
| CA2960274A1 (en) * | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamide compounds |
| US20170253601A1 (en) | 2014-09-10 | 2017-09-07 | Epizyme, Inc. | Substituted Pyrrolidine Compounds |
| WO2016040502A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Substituted cyclohexylamine compounds |
| JP2017528461A (ja) | 2014-09-10 | 2017-09-28 | エピザイム インコーポレイテッド | 置換ピロリジンカルボキサミド化合物 |
| WO2016040511A1 (en) | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamides as irreversible smyd inhibitors |
-
2015
- 2015-09-09 JP JP2017513207A patent/JP2017528464A/ja active Pending
- 2015-09-09 AU AU2015315182A patent/AU2015315182A1/en not_active Abandoned
- 2015-09-09 EP EP15840497.0A patent/EP3193605A4/en not_active Withdrawn
- 2015-09-09 WO PCT/US2015/049235 patent/WO2016040515A1/en not_active Ceased
- 2015-09-09 US US15/510,588 patent/US10577363B2/en active Active
- 2015-09-09 KR KR1020177009316A patent/KR20170047397A/ko not_active Withdrawn
- 2015-09-09 CA CA2960280A patent/CA2960280A1/en not_active Abandoned
- 2015-09-09 MX MX2017002986A patent/MX2017002986A/es unknown
- 2015-09-09 SG SG11201701597RA patent/SG11201701597RA/en unknown
- 2015-09-09 SG SG10201901189SA patent/SG10201901189SA/en unknown
- 2015-09-09 BR BR112017004589A patent/BR112017004589A2/pt not_active Application Discontinuation
- 2015-09-09 EA EA201790327A patent/EA201790327A1/ru unknown
- 2015-09-09 CN CN201580060918.8A patent/CN107072207A/zh active Pending
-
2017
- 2017-03-02 IL IL250888A patent/IL250888A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528464A5 (enExample) | ||
| JP2017527577A5 (enExample) | ||
| JP2017538659A5 (enExample) | ||
| CN115485277B (zh) | 作为HER2抑制剂的[1,3]二嗪基[5,4-d]嘧啶 | |
| JP6884102B2 (ja) | がんの治療のための化合物 | |
| JP2024138293A (ja) | バイオマーカー型治療用組成物 | |
| CN103124729B (zh) | 作为Axl抑制剂的药物活性化合物 | |
| JP2016514695A5 (enExample) | ||
| JP2017526706A5 (enExample) | ||
| Chen et al. | Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl) phenyl) amino) pyrimidin-2-yl) amino)-4-methoxy-2-(4-methyl-1, 4-diazepan-1-yl) phenyl) acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC | |
| JP2023512174A (ja) | ＨＥＲ２阻害薬としての［１，３］ジアジノ［５，４－ｄ］ピリミジン | |
| JP5323289B1 (ja) | 新規ピペリジン化合物又はその塩 | |
| EA201590345A1 (ru) | Способы лечения рака с использованием 3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона | |
| JP2019514950A5 (enExample) | ||
| MA40581A (fr) | Dérivés pyridone utilisés comme inhibiteurs de la kinase réarrangée au cours de la transfection (ret) | |
| EA201391319A1 (ru) | Способ лечения рака с использованием 3-(5-амино-2-метил-4-оксо-4h-хиназолин-3-ил)пиперидин-2,6-диона | |
| CA3094449A1 (en) | Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases | |
| ES2980476T3 (es) | Derivados de tienopiridina y composición farmacéutica que los contiene | |
| JP2015518894A5 (enExample) | ||
| PH12014501947A1 (en) | Serine/threonine kinase inhibitors | |
| JP2015518899A5 (enExample) | ||
| JP2017527577A (ja) | 置換ピロリジン化合物 | |
| TW201245177A (en) | Quinolyl amines as kinase inhibitors | |
| CA2899968A1 (en) | Substituted 2-aminopyridine protein kinase inhibitor | |
| JP2017528461A5 (enExample) |